16,291 reports of this reaction
2.2% of all ACETAMINOPHEN 500MG reports
#6 most reported adverse reaction
HEADACHE is the #6 most commonly reported adverse reaction for ACETAMINOPHEN 500MG, manufactured by Allegiant Health. There are 16,291 FDA adverse event reports linking ACETAMINOPHEN 500MG to HEADACHE. This represents approximately 2.2% of all 734,137 adverse event reports for this drug.
Patients taking ACETAMINOPHEN 500MG who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for ACETAMINOPHEN 500MG, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for ACETAMINOPHEN 500MG:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 16,291 FDA reports for ACETAMINOPHEN 500MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.2% of all adverse event reports for ACETAMINOPHEN 500MG, making it a notable side effect.
If you experience headache while taking ACETAMINOPHEN 500MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.